Diane V. Havlir, MD

Diane Havlir
Global Health Sciences Faculty Affiliate

Phone: 415-476-4082 ext. 400
UCSF Box: 0874
Email: dhavlir@php.ucsf.edu
UCSF Profile

Project
Sponsor Location(s) Topics Start End
ACTG A5295: Evaluation of Xpert MTB/RIF Assay for the Rapid Identification of TB and TB Rifampin Resistance in HIV-Infected and HIV-Uninfected Pulmonary Tuberculosis Suspects Social & Scientific Systems, Inc. United States HIV/AIDS, Tuberculosis
ACTG A5295: Evaluation of Xpert MTB/RIF Assay for the Rapid Identification of TB and TB Rifampin Resistance in HIV-Infected and Uninfected Pulmonary Tuberculosis Suspects Brigham and Women's Hospital United States HIV/AIDS, Tuberculosis
ADS-TCAD-P0206: TCAD Oral for Treatment of Influenza A Adamas Pharmaceuticals, Inc United States Infectious Disease, HIV/AIDS, Opportunistic Infection, Pharmacology and Drug Treatment
Adult AIDS Clinical Trials Unit (AACTU) NIH National Institute of Allergy and Infectious Disease United States HIV/AIDS
AIDS Clinical Trial Group (ACTG) Tuberculosis TSG Services Brigham and Women's Hospital United States HIV/AIDS, Tuberculosis
AIDS Clinical Trial Group Network- Protocol Funding Agreement (Core Funding) Brigham and Women's Hospital United States HIV/AIDS
AIDS Clinical Trial Research Group (ACTG), Studies: A5306, A5254, A5298 Brigham and Women's Hospital Uganda HIV/AIDS, Opportunistic Infection, Tuberculosis, Oral Health
AIDS Clinical Trials Group (ACTG) Community Health Promoter Social & Scientific Systems, Inc. Uganda HIV/AIDS
AIDS Clinical Trials Group (ACTG) TTSG Services Social & Scientific Systems, Inc. United States HIV/AIDS
AIDS Clinical Trials Group: REPRIEVE Trial (A5332 and A5333s) Massachusetts General Hospital United States HIV/AIDS, Cardiovascular Disease
AIDS Clinical Trials Group: REPRIEVE Trial Ancillary Study Brigham and Women's Hospital United States HIV/AIDS, Cardiovascular Disease
AIDS Clinical Trials Group; Protocol Funds Brigham and Women's Hospital United States HIV/AIDS
AIDS Research and Services at SF General Hospital East Bay Community Foundation United States HIV/AIDS, Engagement in Care, Treatment Adherence, Risk Reduction and Prevention
AIDS Research and Services at SFGH East Bay Community Foundation United States HIV/AIDS
Cardiovascular, Anthropometric, and Skeletal Effects of ART Initiation with FTC/TDF plus ATV/r: Metabolic Substudy of A5257 (ACTG A5260s) Social & Scientific Systems, Inc. United States HIV/AIDS
Clinical Care Response Team Introduction of Antiretroviral Therapy in Elizabeth Glaser Pediatric AIDS Foundation Sites Elizabeth Glaser Pediatric AIDS Foundation Kenya; Uganda; Tanzania; Zimbabwe; South Africa; Ivory Coast HIV/AIDS, Pediatrics
Clinical Care Response Team Introduction of Antiretroviral Therapy in Elizabeth Glaser Pediatric AIDS Foundation Sites Elizabeth Glaser Pediatric AIDS Foundation Uganda HIV/AIDS, Engagement in Care, Health Systems Strengthening, Training and Capacity Building
Clinical Studies of Interactions Between HIV and Malaria NIH National Institute of Allergy and Infectious Disease Uganda HIV/AIDS, Malaria
Effect of low dose methotrexate on endothelial function and inflammation in HIV - A5314 Brigham and Women's Hospital United States HIV/AIDS, Pharmacology and Drug Treatment
Getting to Zero Coordinator/ SFPHF San Francisco Public Health Foundation United States HIV/AIDS
Heals Endowment Fund at the East Bay Community Foundation East Bay Community Foundation United States HIV/AIDS
HIV/TB in Uganda: Punctuated Antiretroviral Therapy University of Georgia Uganda; South Africa HIV/AIDS, Tuberculosis
HIV/TB in Uganda: Punctuated Antiretroviral Therapy Case Western Reserve University Uganda; South Africa HIV/AIDS, Tuberculosis
International AIDS Research and Prevention Pangaea Global AIDS Foundation Uganda HIV/AIDS
Neurological AIDS Research Consortium Washington University in St. Louis United States HIV/AIDS
Novel Strategies to Prevent Malaria and Improve HIV Outcomes in Africa (I) NIH National Institute of Child Health and Human Development Uganda HIV/AIDS, Malaria
Novel Strategies to Prevent Malaria and Improve HIV Outcomes in Africa (III) Abbott Laboratories Uganda HIV/AIDS, Malaria
Novel Strategies to Prevent Malaria and Improve HIV Outcomes in Uganda (II) Abbott Laboratories Uganda HIV/AIDS
Novel Strategies to Prevent Malaria and Improve Maternal-Child Health in Africa (PROMOTE) NIH National Institute of Child Health and Human Development Uganda HIV/AIDS, Malaria, Pharmacology and Drug Treatment, Women's Health, Pediatrics, Newborn and Infant Health
Productive and Latent HIV Infection in Gut Mucosal Reservoirs Northern California Institute for Research and Education, Inc. (NCIRE) United States HIV/AIDS
Reducing Failure-to-Initiate ART: Streamlined ART Start NIH National Institute of Allergy and Infectious Disease Uganda HIV/AIDS, Access or Barriers to Care, Implementation and Behavioral Science, Engagement in Care
Reducing Failure-to-Initiate ART: Streamlined ART Start Strategy (START) NIH National Institute of Allergy and Infectious Disease Uganda HIV/AIDS
SEARCH (Sustained East Africa Research in Community Health) Study in Kenya and Uganda/ Gates Bill & Melinda Gates Foundation Kenya; Uganda HIV/AIDS, Tuberculosis, Malaria, Cardiovascular Disease, Diabetes
Study of Three NNNRTI-Sparing Antiretroviral Regimens for Treatment-Naive HIV-1-Infected Volunteers (ACTG A5257) Social & Scientific Systems, Inc. Puerto Rico HIV/AIDS, Pharmacology and Drug Treatment
Supplement to ATCG A5254: Assessing HIV-Related Oral Mucosal Disease and Using Saliva to Measure Viral Load Social & Scientific Systems, Inc. Haiti HIV/AIDS
Task Order # 6: Supplement to SSS A5257 Social & Scientific Systems, Inc. United States HIV/AIDS
Task Order # 7: Supplement to SSS A5254 Social & Scientific Systems, Inc. United States HIV/AIDS, Opportunistic Infection, Oral Health
Task Order # 9: Supplement to SSS A5272 Social & Scientific Systems, Inc. United States HIV/AIDS, Pharmacology and Drug Treatment
Task Order A5280: A Prospective, Randomized Pilot Trial of High Dose Vitamin D and Calcium for Bone Health in HIV-Infected Individuals Initiating Highly Active Antiretroviral Therapy (HAART) Social & Scientific Systems, Inc. United States HIV/AIDS
Task Order A5303: Trial to Determine the Bone, Immunologic, Virologic, and Neurocognitive Effects of a Novel Maraviroc-Containing Antiretroviral Regimen in Treatment-Naive Patients Infected with R5-Tropic HIV-1 Social & Scientific Systems, Inc. Uganda HIV/AIDS, Pharmacology and Drug Treatment
Task Order Agreement No. CRB-DCR01-S-09-00325 Social & Scientific Systems, Inc. United States Drug and Diagnostics Development
Task Order Supplement to A5267 Social & Scientific Systems, Inc. United States HIV/AIDS, Tuberculosis, Pharmacology and Drug Treatment
Therapeutic Strategies for HIV Disease NIH National Institute of Allergy and Infectious Disease Uganda HIV/AIDS
Therapeutic Strategies for HIV Disease NIH National Institute of Allergy and Infectious Disease Uganda HIV/AIDS
TO#5 ACTG-Clinical Research Site - Community Health Promoter Position Social & Scientific Systems, Inc. United States HIV/AIDS
Training in HIV Primary Care - Uganda Clinicians Elizabeth Glaser Pediatric AIDS Foundation Uganda HIV/AIDS, Training and Capacity Building
Training in HIV Translational Research NIH National Institute of Allergy and Infectious Disease United States Training and Capacity Building
Training in HIV Translational Research NIH National Institute of Allergy and Infectious Disease United States HIV/AIDS, Training and Capacity Building
Trial of Raltegravir Plus Darunavir/Ritonavir for Treatment-Naive HIV-1-Infected Subjects (ATCG A5262) Social & Scientific Systems, Inc. United States HIV/AIDS, Pharmacology and Drug Treatment
UCSF HIV Clinical Trials Unit NIH National Institute of Allergy and Infectious Disease United States HIV/AIDS
UCSF HIV/AIDS Management Training Programs Public Health Institute United States HIV/AIDS, Training and Capacity Building